The cost of healthcare remains a focus for governments and communities around the world. While our investment in healthcare has been rising over decades, and with it improved health outcomes and life expectancy, the need for new and additional healthcare continues to grow. The Organisation for Economic Co-operation and Development’s (OECD) 2017 report Health at a Glance says that whilst people in OECD member countries are living longer, they are suffering more from chronic and mental illnesses.
How does the UK align with global trends in healthcare investment and pharmaceutical markets, and how does the UK pharmaceutical industry contribute to the UK’s economic growth and prosperity? Find out more below.